Novartis to License Drug From China’s Abogen in Up to $7.8 Billion Deal
Abogen said its lead drug has potential to transform the treatment landscape for patients with autoimmune diseases.
Connecting Global Economies
Flash News
They’re Known as Swarm Chasers—and They Spring Into Action When AI Goes Rogue
Novartis signs $7.8 billion Abogen biotech licensing deal
UGGs on Sale at DSW: UGG Slippers Under $100
Novartis to License Drug From China’s Abogen in Up to $7.8 Billion Deal
Nike stock falls 10% after revenue falls and layoff plans underway
Inside Tom Cruise's Epic Romantic History
AI Agents Aim to Change Shopping. Some Retailers Are Locking the Doors.
Hundreds of French high schools shut as new violence erupts
Oil prices fall on report of potential European diesel stock release
Ruby Rose Falsely Accused of Child Murder as Teen After Playground Accident
Friday, October 02, 2026
